Afficher la couverture 'Correction: A novel therapeutic approach to colorectal cancer in diabetes: role of metformin and rapamycin | Gerges Geagea, Alice' en grand format
/5

0 avis

Correction: A novel therapeutic approach to colorectal cancer in diabetes: role of metformin and rapamycin

Archive ouverte

Gerges Geagea, Alice | Rizzo, Manfredi | Jurjus, Abdo | Cappello, Francesco | Leone, Angelo | Tomasello, Giovanni | Gracia, Céline | Al Kattar, Sahar | Massaad-Massade, Liliane | Eid, Assaad

Edité par CCSD ; Impact journals -

International audience. Correction Figure 4: Prototype of tumors upon sacrifice, formed in non-diabetic and diabetic mice treated with rapamycin, metformin and their combination with probiotics. Note the difference in tumor size in the different groups; animals from groups 4B and 8B treated with rapamycin and metformin in combination with probiotics had significantly smaller tumor size when compared to groups treated with Met alone, rapamycin alone or untreated animals.

Suggestions

Du même auteur

A novel therapeutic approach to colorectal cancer in diabetes: role of metformin and rapamycin

Archive ouverte | Gerges Geagea, Alice | CCSD

International audience. The link between colorectal cancer (CRC), diabetes mellitus (DM) and inflammation is well established, and polytherapy, including rapamycin, has been adopted. This study is a novel approach t...

Metformin and Probiotics in the Crosstalk between Colitis-Associated Colorectal Cancer and Diabetes in Mice

Archive ouverte | Al Kattar, Sahar | CCSD

International audience

New Formulation for the Delivery of Oligonucleotides Using “Clickable” siRNA-Polyisoprenoid-Conjugated Nanoparticles: Application to Cancers Harboring Fusion Oncogenes

Archive ouverte | Massaad-Massade, Liliane | CCSD

International audience

Chargement des enrichissements...